NUCLEOLIN and non-small cell lung carcinoma: NCL expression was associated with the grade and clinical stage in glioblastoma, hepatocellular carcinoma, and non-small-cell lung cancer [15,43], whereas no significant difference was observed in pancreatic ductal carcinoma and gastric cancer [40,41].